Bain Capital Specialty Finance, Inc. current report, 19 February 2019

Business Context and Reporting Period

This Form 8-K was filed by Bain Capital Specialty Finance, Inc. on February 19, 2019. The report details the entry into a material definitive agreement and the creation of a direct financial obligation on the same date. The Company is an emerging growth company incorporated in Delaware.

Key Financial Metrics

The filing establishes a new credit facility with the following terms:

  • Facility Amount: $350,000,000
  • Interest Rate (Reinvestment Period): Three-month LIBOR plus 1.60%
  • Interest Rate (Post-Reinvestment): Three-month LIBOR plus 2.60%
  • Reinvestment Period: From closing date until February 19, 2020
  • Final Maturity Date: February 19, 2022 (subject to earlier notice or default)

The filing text does not provide values for revenue, profit, cash flow, margins, or existing liquidity positions.

Material Changes

The primary material change is the execution of a Credit Agreement with Citibank, N.A. as Administrative Agent and Wells Fargo Bank, National Association as Collateral Administrator. This agreement creates a new $350 million revolving credit facility intended for the acquisition of qualifying loans and other permitted uses.

Outlook, Risks, and Covenants

The Credit Agreement includes customary affirmative and negative covenants, specifically limiting the incurrence of additional indebtedness and liens. Usual and customary events of default for revolving credit facilities apply. The full text of the agreement will be filed as an exhibit to the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2018.

Investor Verification Checklist

  • Verify the specific limitations on additional indebtedness and liens within the full Credit Agreement.
  • Confirm the exact definition of "qualifying loans" eligible for acquisition with the facility proceeds.
  • Review the full list of events of default to understand potential acceleration triggers.
  • Monitor the Company's utilization of the $350 million facility during the reinvestment period.